Cleft Palate Research Today is a free monthly online journal that collates and summarizes the latest research about Cleft Palate, including details on causes, surgery, treatment.

Maternal corticosteroid use and orofacial clefts.

Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ,

March of Dimes Foundation/California Department of Health Services, California Birth Defects Monitoring Program, Berkeley, CA, USA. SCarmichael@marchofdimes.com

OBJECTIVE: The purpose of this study was to examine whether maternal corticosteroid use during pregnancy is associated with delivering an infant with an orofacial cleft. STUDY DESIGN: This study included data on deliveries from the National Birth Defects Prevention Study, which is a population-based case-control study. Exposures were assessed by telephone interviews for mothers of 1141 cases with cleft lip +/- cleft palate (CLP), 628 with cleft palate (CP), and 4143 controls. RESULTS: Mothers of 33 infants with CLP (2.9%), mothers of 6 infants with CP (1.0%), and 72 control subjects (1.7%) reported corticosteroid use from 4 weeks before through 12 weeks after conception. The crude odds ratio for "any" vs "no" use was 1.7 (95% CI, 1.1-2.6) for CLP and 0.5 (0.2-1.3) for CP. When analyzed by route of administration and medication components, odds ratios for CLP tended to be elevated, and odds ratios for CP tended to be close to 1. CONCLUSION: Our results suggest a moderately increased risk of CLP among women who use corticosteroids during early pregnancy.

Published 6 December 2007 in Am J Obstet Gynecol, 197(6): 585.e1-7; discussion 683-4, e1-7.
Full-text of this article is available online (may require subscription).

© 2005-2008 Cleft Palate Research Today. All Rights Reserved.